In order to investigate the effect of PDPN+ myeloid cells on glioma development, we generated a mouse line that carries a myeloid-specific deletion of Pdpn by crossing a Pdpnflox/flox with a Csf1r-Cre transgenic line (Figure 2A). The gene discussed is CSF1R; the disease is central nervous system cancer.